Agonists for the Chemokine Receptor CXCR4
Open Access
- 15 June 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Medicinal Chemistry Letters
- Vol. 2 (8) , 597-602
Abstract
The development of agonists for the chemokine receptor CXCR4 could provide promising therapeutic candidates. On the basis of previously forwarded two site model of chemokine–receptor interactions, we hypothesized that linking the agonistic N-terminus of SDF-1 to the T140 backbone would yield new high-affinity agonists of CXCR4. We developed chimeras with the agonistic SDF-1 N-terminus grafted to a T140 side chain and tested their binding affinity and chemotactic agonist activity. While chimeras with the peptide grafted onto position 12 of T140 remained high-affinity antagonists, those bearing the peptide on position 14 were in part agonists. One chimera was a full CXCR4 agonist with 25 nM affinity, and several chimeras showed low nanomolar affinities with partial agonist activity. Our results confirmed that we have developed high-affinity agonists of CXCR4.Keywords
This publication has 25 references indexed in Scilit:
- Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cellsProceedings of the National Academy of Sciences, 2010
- Recent advances on the use of the CXCR4 antagonist plerixafor (AMD3100, Mozobil™) and potential of other CXCR4 antagonists as stem cell mobilizersPharmacology & Therapeutics, 2010
- Structures of the CXCR4 Chemokine GPCR with Small-Molecule and Cyclic Peptide AntagonistsScience, 2010
- CXCL12 (SDF-1)/CXCR4 Pathway in CancerClinical Cancer Research, 2010
- Constitutive CXCL12 Expression Induces Anoikis in Colorectal Carcinoma CellsGastroenterology, 2008
- Epigenetic silencing of CXCL12 increases the metastatic potential of mammary carcinoma cellsOncogene, 2007
- Small Peptide Analogue of SDF-1α Supports Survival of Cord Blood CD34+ Cells in Synergy with Other Cytokines and Enhances Their Ex Vivo Expansion and Engraftment into Nonobese Diabetic/Severe Combined Immunodeficient MiceStem Cells, 2006
- The CXCR4 agonist peptide, CTCE-0021, rapidly mobilizes polymorphonuclear neutrophils and hematopoietic progenitor cells into peripheral blood and synergizes with granulocyte colony-stimulating factorExperimental Hematology, 2005
- Pharmacological evidence for complex and multiple site interaction of CXCR4 with SDF-1α: implications for development of selective CXCR4 antagonistsImmunology Letters, 2001
- Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4Science, 1999